Prognosis of Multiple Myeloma


advertisement

About prognosis: The 'prognosis' of Multiple Myeloma usually refers to the likely outcome of Multiple Myeloma. The prognosis of Multiple Myeloma may include the duration of Multiple Myeloma, chances of complications of Multiple Myeloma, probable outcomes, prospects for recovery, recovery period for Multiple Myeloma, survival rates, death rates, and other outcome possibilities in the overall prognosis of Multiple Myeloma. Naturally, such forecast issues are by their nature unpredictable.

Survival rate statistics for Multiple Myeloma: The following are statistics from various sources about the survival rate for Multiple Myeloma:
  • 31% of white people survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 33% of African American people survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 32% survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with multiple myeloma is 29.4% in the US 1983-90 (SEER)
  • 5-year survival rate for people with multiple myeloma is 27.7% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with multiple myeloma is 27.4% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with myeloma is 57.7% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with myeloma is 19.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with myeloma is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with myeloma is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with myeloma is 84% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with myeloma is 42% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with myeloma is 76% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with myeloma is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with myeloma is 66% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with myeloma is 24% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with myeloma is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with myeloma is 14% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with myeloma is 37% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with myeloma is 8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with myeloma is 59.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with myeloma is 20.5% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with myeloma is 88% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with myeloma is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with myeloma is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with myeloma is 40% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with myeloma is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with myeloma is 36% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with myeloma is 66% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with myeloma is 23% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with myeloma is 57% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with myeloma is 17% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with myeloma is 38% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with myeloma is 9% in England and Wales 1991-95 (Cancer Survival, National Statistics)

Deaths from Multiple Myeloma: 11,016 deaths reported in USA 1999 for multiple myeloma and other immunoproliferative syndromes (NVSR Sep 2001)
Complications: see complications of Multiple Myeloma

Prognosis of Multiple Myeloma discussion: Plasmacytoma and multiple myeloma are very hard to cure. Although patients who have a plasmacytoma may be free of symptoms for a long time after treatment, many eventually develop multiple myeloma. For those who have multiple myeloma, treatment can improve the quality of a patient's life by controlling the symptoms and complications of the disease.1

Footnotes:
1. excerpt from What You Need To Know About Multiple Myeloma: NCI

Last revision: June 2, 2003

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise